A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
ACTIVE_NOT_RECRUITING
Status
Conditions
- Ewing Sarcomas
- Chondrosarcomas
- Osteosarcomas
- Chondroma
- CIC-Rearranged Sarcoma
Interventions
- DRUG: Regorafenib
- DRUG: Placebo
Sponsor
UNICANCER